Skip to content
healthcare.dev

Maxiclens Chlorhexidine Gluconate Liquid Solution, 4%

NDC 0404-0219, Chlorhexidine Gluconate, solution, from Henry Schein, Inc..

Product NDC
0404-0219
Status
Listed
Labeler
Henry Schein, Inc.
Dosage form
SOLUTION
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
NDA
Application
NDA019258
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0404-0219 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CHLORHEXIDINE GLUCONATE40 mg/mL

Pharmacologic classes

Decreased Cell Wall Integrity [PE]

Package NDCNDC-11Package
0404-0219-0100404021901118 mL in 1 BOTTLE (0404-0219-01)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0404-0219 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0404-0219 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0404-0219. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.